Latest filing published 11 Aug 2016 for Edwards Lifesciences Corp, €506k.
No signal scores available.
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
John T. Cardis discloses dealings in 3 companies, chiefly Avery Dennison Corp, Edwards Lifesciences Corp and Energy East Corp. Over a trading history stretching from 27 April 2006 to 10 August 2016, the count stands at 41 filings.
On the open market, the record shows 2 purchases worth €190k and 8 sales worth €2.6M. Taken together, the sales exceed the purchases by €2.4M. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 16 share grants and 15 option exercises. Since January 2016: no purchases and 1 sale on the market.
The record was last updated on 11 August 2016 with an open-market sale (€506k) in Edwards Lifesciences Corp. The last insider purchase was made public on 30 January 2009, 6,475 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 35 declarations